Eleonore Pauwels is a writer and international science policy expert, who specializes in the governance of emerging and converging technologies. At the Wilson Center, she is the Director of Biology Collectives, within the Science and Technology Innovation Program. Her research focuses on the convergence of transformative technologies such as artificial intelligence, genome-editing, digital bio-engineering and automation technologies. She analyzes the promises and perils that will likely arise with the development of the Internet of Living Things and future networks of intelligent and connected bio-labs. Her work also fosters the democratization of disruptive health technologies, including AI and genomics, and the inclusion of patients and citizens through participatory health design (her Citizen Health Innovators Project). In this context, her research focuses on developing regulatory and
governance mechanisms for the fast-growing ecosystem of health innovators, built around maker spaces and community bio labs, to support responsible innovation in distributed networks. This is part of her larger effort to design actionable ethics and governance strategies to enable responsible and fair citizen participation in new health and genomics technologies.
Eleonore regularly testifies before U.S. and European authorities including the U.S. Department of State, NAS, NIH, NCI, FDA, the National Intelligence Council, the European Commission and the UN. But she is also well-versed in communicating complex and novel scientific developments for lay audiences (her TEDxCERN on CRISPR) and her writing has been featured in media outlets such as Nature, The New York Times, The Guardian, Scientific American, Le Monde, Slate and The Miami Herald.